Bank of Montreal
RNAM

Bank of Montreal’s Avidity Biosciences RNAM Stock Holding History

Bank of Montreal’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,648
Closed -$243 – 4370
2022
Q2 		$243 Buy
+16,648
New +$248K ﹤0.01% 3148
2021
Q2 		– Sell
-1,021
Closed -$25K – 4706
2021
Q1 		$25K Sell
1,021
-1,565
-61% -$38.3K ﹤0.01% 3973
2020
Q4 		$71K Buy
2,586
+1,811
+234% +$52.8K ﹤0.01% 3771
2020
Q3 		$23K Buy
+775
New +$22.4K ﹤0.01% 3778

Other funds holding RNAM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of Montreal's RNAM Position: Q3 2022 in Review

Bank of Montreal sold out of Avidity Biosciences (RNAM) in Q3 2022, closing a stake of 16,648 shares — an estimated $243 sold.

Bank of Montreal first reported a position in RNAM in Q3 2020 and held it in 4 quarters. The position peaked at $71K in Q4 2020. 127 funds tracked by Wall St. Rank hold RNAM as of Q3 2022.

  • Bank of Montreal reported no remaining Avidity Biosciences position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 16,648 Avidity Biosciences shares in Q3 2022, an estimated $243.
  • Bank of Montreal first reported a position in Avidity Biosciences in Q3 2020 and held it in 4 quarters.
  • Bank of Montreal's Avidity Biosciences position peaked at $71K in Q4 2020.
  • 127 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.